You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

14-110

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021

Sepsis, Acute Kidney Injury, Septic Shock Trial in Worldwide (Subject management guided by NephroCheck® test, Standard of Care)

Terminated
  • Sepsis
  • +2 more
  • Subject management guided by NephroCheck® test
  • Standard of Care
  • Shreveport, Louisiana
  • +11 more
Feb 28, 2022

Cancer Trial in Worldwide (Dabrafenib, Trametinib)

Completed
  • Cancer
  • Little Rock, Arkansas
  • +51 more
Jun 8, 2022

Coronary Artery Disease Trial in Worldwide (Inclisiran sodium 300 mg, Placebo)

Recruiting
  • Coronary Artery Disease
  • Inclisiran sodium 300 mg
  • Placebo
  • Huntsville, Alabama
  • +54 more
Jan 31, 2023

Tourette Syndrome Trial in Hannover, Tel Aviv (SCI-110, Placebo)

Not yet recruiting
  • Tourette Syndrome
  • Hannover, Germany
  • +1 more
Oct 25, 2022

Lung Infection, Pneumonia, Ventilator-Associated, Infection, Bacterial Trial in Worldwide (AR-301, Placebo)

Recruiting
  • Lung Infection
  • +3 more
  • Sacramento, California
  • +139 more
Feb 25, 2022

Heart Diseases, Lung Diseases Trial in Sao Paulo (Assessment Respiratory and Neuromuscular)

Completed
  • Heart Diseases
  • Lung Diseases
  • Assessment Respiratory and Neuromuscular
  • Sao Paulo, São Paulo, Brazil
    Alcino Costa Leme
Feb 1, 2023

Myocardial Infarction Trial in Bern, Geneve (Alcohol consumption)

Recruiting
  • Myocardial Infarction
  • Alcohol consumption
  • Bern, Switzerland
  • +1 more
Jun 16, 2023

Eosinophils, Asthma Trial in Worldwide (reslizumab)

Terminated
Has Results
  • Eosinophils, Asthma
  • Birmingham, Alabama
  • +133 more
Dec 9, 2022

Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

Recruiting
  • Tuberous Sclerosis Complex
  • Basimglurant with crossover to Placebo
  • Placebo with crossover to Basimglurant
  • Phoenix, Arizona
  • +47 more
Jan 3, 2023

Food Insecurity Trial in San Francisco (Monetary benefit to purchase fruits and vegetables)

Not yet recruiting
  • Food Insecurity
  • Monetary benefit to purchase fruits and vegetables
  • San Francisco, California
    University of California, San Francisco
Jul 28, 2023

Healthy, Nutritional and Metabolic Diseases Trial in México (Dietary Supplement: A package containing a mix of functional foods)

Not yet recruiting
  • Healthy
  • Nutritional and Metabolic Diseases
  • Dietary Supplement: A package containing a mix of functional foods
  • México, Mexico City, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Feb 1, 2023

High Risk Prostate Carcinoma Trial in Gyeonggi-do, Seoul ([F-18]Florastamin)

Completed
  • High Risk Prostate Carcinoma
  • Gyeonggi-do, Korea, Republic of
  • +4 more
Dec 8, 2022

Advanced Solid Tumor Trial in Portland (HS-110 (viagenpumatucel-L), HS-130)

Active, not recruiting
  • Advanced Solid Tumor
  • HS-110 (viagenpumatucel-L)
  • HS-130
  • Portland, Oregon
    Providence Portland Medical Center
Feb 2, 2022

Refractory Chronic Cough Trial in United Kingdom, United States (5 mg Serlopitant Tablets, Matching Placebo Tablets)

Completed
Has Results
  • Refractory Chronic Cough
  • 5 mg Serlopitant Tablets
  • Matching Placebo Tablets
  • Los Angeles, California
  • +38 more
May 18, 2021

Obesity Trial in Oggebbio (Whole-body cryostimulation (WBC), Rehabilitation program)

Completed
  • Obesity
  • Whole-body cryostimulation (WBC)
  • Rehabilitation program
  • Oggebbio, Verbano-Cusio-Ossola, Italy
    IRCCS Istituto Auxologico Italiano Ospedale San Giuseppe
Jul 1, 2022

Long COVID Trial in Hong Kong (Chinese medicine nutritional supplement Cs4)

Recruiting
  • Long COVID
  • Chinese medicine nutritional supplement Cs4
  • Hong Kong, China
    The School of Chinese Medicine, HKU
Sep 26, 2023

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • New Port Richey, Florida
  • +94 more
Nov 30, 2022

Gout Chronic, Hyperuricemia Trial in United States (SEL-212, SEL-037, SVP-rapamycin (SEL-110))

Completed
Has Results
  • Gout Chronic
  • Hyperuricemia
  • Anaheim, California
  • +12 more
Jan 31, 2022

Rosuvastatin and Evolocumab for Coronary Artery Disease

Completed
  • Coronary Artery Disease
  • New York, New York
    Mount Sinai Hospital
Aug 2, 2023

Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +

Completed
  • Primary Open Angle Glaucoma of Both Eyes
  • Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
  • Cosopt eye drops, 20 mg/mL + 5 mg/mL
  • Kazan, Russian Federation
    Republican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)

Not yet recruiting
  • Nasal Polyps
  • Shiraz, Fars, Iran, Islamic Republic of
    Imam Reza Allergy and Immunology clinic, Shiraz University of Me
May 31, 2022

Heart Failure With Preserved Ejection Fraction, Beta Blocker, Myocardial Strain Trial in Seoul, Wonju (Carvedilol, Placebo)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • +2 more
  • Seoul, Il-won, Korea, Republic of
  • +1 more
Oct 18, 2022

Bunion Trial in Bellaire (Ropivacaine)

Recruiting
  • Bunion
  • Bellaire, Texas
    First Surgical Hospital 4801 Bissonnet Street
Mar 6, 2023